CheckMyRecalls

Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin…

Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin Tablets

Published
18 Jun 2025
Units affected
6,759 Con - 90 bottle pack
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lot #: 17240195, Exp 01/31/2026.
Distribution
Nationwide USA and PR
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 18 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.